253 related articles for article (PubMed ID: 15215161)
21. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
[TBL] [Abstract][Full Text] [Related]
22. The epitope study of alpha-fodrin autoantibody in primary Sjögren's syndrome.
Chen Q; Li X; He W; Zhang H; Gao A; Cheng Y; Lei J; Li S; Zeng L
Clin Exp Immunol; 2007 Sep; 149(3):497-503. PubMed ID: 17614976
[TBL] [Abstract][Full Text] [Related]
23. Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjögren's syndrome-associated autoimmune sialadenitis.
Wang Y; Shnyra A; Africa C; Warholic C; McArthur C
Arch Oral Biol; 2009 Nov; 54(11):986-96. PubMed ID: 19716548
[TBL] [Abstract][Full Text] [Related]
24. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
26. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Mishima K; Arakaki R; Suda T; Saito I; Hayashi Y
J Immunol; 2002 Jul; 169(2):1050-7. PubMed ID: 12097413
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
Szántó A; Csípo I; Zeher M
J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
[No Abstract] [Full Text] [Related]
28. Prevalence of antibodies against alpha-fodrin in Sjögren's syndrome: comparison of 2 sets of classification criteria.
Witte T; Matthias T; Oppermann M; Helmke K; Peter HH; Schmidt RE; Tishler M
J Rheumatol; 2003 Oct; 30(10):2157-9. PubMed ID: 14528510
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of epitopes recognized by anti-alpha-fodrin autoantibodies in children with Sjogren's syndrome].
Shiari R
Hokkaido Igaku Zasshi; 2005 Sep; 80(5):441-7. PubMed ID: 16238239
[No Abstract] [Full Text] [Related]
30. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
He J; Zhao J; Li Z
Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
[TBL] [Abstract][Full Text] [Related]
31. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
Hayashi Y; Yayagi K; Haneji N
Arch Immunol Ther Exp (Warsz); 2000; 48(5):399-403. PubMed ID: 11140467
[TBL] [Abstract][Full Text] [Related]
32. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.
Kahaly GJ; Bang H; Berg W; Dittmar M
Clin Exp Immunol; 2005 Apr; 140(1):166-72. PubMed ID: 15762888
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of anti-alpha-fodrin antibody testing for Sjögren's syndrome: a meta-analysis].
Huang QS; LE AP; Luo ZQ; Li JM; Wang WQ; Ju BH; Wan LG
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2971-6. PubMed ID: 19080074
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
Locht H; Pelck R; Manthorpe R
J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
[TBL] [Abstract][Full Text] [Related]
37. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
[TBL] [Abstract][Full Text] [Related]
38. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
39. Identification of tear lipocalin as a novel autoantigen target in Sjögren's syndrome.
Navone R; Lunardi C; Gerli R; Tinazzi E; Peterlana D; Bason C; Corrocher R; Puccetti A
J Autoimmun; 2005 Nov; 25(3):229-34. PubMed ID: 16249071
[TBL] [Abstract][Full Text] [Related]
40. Anti-cytoplasmic autoantibodies reactive with epithelial cells of the salivary gland in sera from patients with Sjögren's syndrome: their disease- and organ-specificities.
Sakamoto M; Miyazawa M; Mori S; Fujisawa R
J Oral Pathol Med; 1999 Jan; 28(1):20-5. PubMed ID: 9890453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]